BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Tyme Provides Update on At-The-Market Financing Activity

  Between November 6 and December 4, 2017, the Company sold approximately 1.2 million shares of Tyme common stock at an average price of $4.05 per share.

  December 5, 2017

   · 

  4 min read
• 

  Business

  Purigen Biosystems Appoints Life Science Industry Veteran Barney Saunders, PhD, as CEO

  Dr. Saunders brings 30 years of experience managing emergent technologies and commercializing disruptive products for life science tools and diagnostics companies.

  December 5, 2017

   · 

  2 min read
• Drug Development

  Immunovaccine Announces Positive Clinical Data from Its Collaborative Combination Immunotherapy Trial in Advanced Ovarian Cancer

  Initial results from ten evaluable patients in the DPX-Survivac plus 100 mg epacadostat dosing cohort demonstrate a disease control rate of 70%.

  December 5, 2017

   · 

  7 min read
• Drug Development

  ObsEva Initiates PROLONG, the Phase IIa Clinical Trial of OBE022 in Preterm Labor

  The PROLONG trial is the first clinical trial of OBE022 in pregnant women presenting with spontaneous preterm labor at gestational ages between 24 and 34 weeks.

  December 5, 2017

   · 

  7 min read
• 

  BioForest

  Neuropace’s Brain Implant Reduces Epilepsy Seizures in 8-Year Trial

  Key findings from these prospective trials demonstrate sustained, long-term patient benefits.

  December 5, 2017

   · 

  4 min read
• Business

  Plasticell and Anthony Nolan to Partner in Clinical Trials of Ex Vivo Expanded Cord Blood Stem Cells

  The project is part of Plasticell’s hematopoietic cell therapy portfolio, which includes the expansion of hematopoietic stem cells and the manufacture of various blood cell types from pluripotent cell sources.

  December 5, 2017

   · 

  3 min read
• Business

  CluePoints Responds to Sponsor and CRO Demand with Two New Appointments

  CluePoints, a leading provider of RBM and Data Quality Oversight solutions for clinical trials, has announced two new strategic appointments to strengthen its business development team.

  December 5, 2017

   · 

  2 min read
• BioForest

  Kubota Pharmaceutical Holdings Co., Ltd. Announces Intention to Terminate SEC Reporting Obligations

  The termination of the Company’s registration and reporting obligations under Section 13(a) and Section 15(d) of the Exchange Act is expected to be effective 90 days after filing of Form 15F.

  December 5, 2017

   · 

  3 min read
• Quality First International Release: Understanding the Black Sheep of Standards: An Analysis of EN ISO 14630 on Non-Active Surgical Implants and Practicalities of its Application

  Haroon Atchia - CEO of the Quality First International - has written a profound analysis on the controversial standard EN ISO 14630.

  December 5, 2017

   · 

  2 min read
• Biotech Beach

  Cianna Medical Launches Comprehensive Support Program to Support Health Systems’ Mission of ‘Moving Beyond Wires’ for Breast Tumor Localization

  The company introduced the program at the 2017 San Antonio Breast Cancer Symposium taking place from December 5-9, 2017, in San Antonio, Texas.

  December 5, 2017

   · 

  4 min read